艾迪药业：拟与北京安普共同向参股公司艾普医学增资1000万元

Core Viewpoint - Eddie Pharmaceuticals (688488.SH) announced a capital increase of 10 million yuan in its subsidiary, Aipu Medical, in collaboration with Beijing Anpu, maintaining their respective shareholding ratios [1] Group 1: Company Actions - The company plans to invest 3.5 million yuan to subscribe for an increase in registered capital of 3.5 million yuan [1] - Beijing Anpu will invest 6.5 million yuan to subscribe for an increase in registered capital of 6.5 million yuan [1] - The capital increase is proportionate to their original shareholding, ensuring that the ownership structure remains unchanged post-investment [1] Group 2: Industry Focus - Aipu Medical specializes in third-party medical testing services, with a focus on the HIV field and other potentially profitable areas of medical testing services [1]